# Hekate Health Sciences Inc. — Form D

Hekate Health Sciences Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-05. The offering totals $330K, of which $330K was reported sold. Industry: Other.

## Offering

- Filed: 2022-10-05
- Form: D
- Accession: 0001062993-22-020505
- Industry: Other
- Exemptions: 06b
- Total offering: $330K
- Amount sold: $330K
- Investors: 3
- Date of first sale: 2022-07-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460838

## Issuer

- Name: Hekate Health Sciences Inc.
- CIK: 0001949705
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2018
- Address: 142-757 WEST HASTINGS STREET, VANCOUVER, A1, V6C 1A1
- Phone: 1-250-664-0439

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Justin Kates | Director | Vancouver, A1 |
| Vasek Pospisil, | Director | Vancouver, A1 |
| Vasek Pospisil, | Executive Officer | Vancouver, A1 |

## More

- [CIK 1949705 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1949705&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001062993-22-020505.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.